A Ghosh1, G Philiponis1, A Bewley2, E R Ransom3, N Mirza1. 1. Department of Otorhinolaryngology: Head and Neck Surgery,University of Pennsylvania,Philadelphia,USA. 2. Department of Otorhinolaryngology,University of California,Davis,USA. 3. Center for Facial Plastic,Reconstructive, and Laser Surgery,San Francisco,California,USA.
Abstract
OBJECTIVE: A prospective randomised study was conducted at a tertiary care hospital to evaluate the effects of financial incentives for smoking cessation targeted at a high-risk population. METHODS:Patients with a past history of head and neck cancer were voluntarily enrolled over a two-year period. They were randomised to a cash incentives or no incentive group. Subjects were offered enrolment in smoking cessation courses. Smoking by-product levels were assessed at 30 days, 3 months and 6 months. Subjects in the incentive group received $150 if smoking cessation was confirmed. RESULTS: Over 2 years, 114 patients with an established diagnosis of head and neck cancer were offered enrolment. Twenty-four enrolled and 14 attended the smoking cessation classes. Only two successfully quit smoking at six months. Both these patients were in the financially incentivised group and received $150 at each test visit. CONCLUSION: Providing a financial incentive for smoking cessation to a population already carrying a diagnosis of head and neck cancer in order to promote a positive behaviour change was unsuccessful.
RCT Entities:
OBJECTIVE: A prospective randomised study was conducted at a tertiary care hospital to evaluate the effects of financial incentives for smoking cessation targeted at a high-risk population. METHODS:Patients with a past history of head and neck cancer were voluntarily enrolled over a two-year period. They were randomised to a cash incentives or no incentive group. Subjects were offered enrolment in smoking cessation courses. Smoking by-product levels were assessed at 30 days, 3 months and 6 months. Subjects in the incentive group received $150 if smoking cessation was confirmed. RESULTS: Over 2 years, 114 patients with an established diagnosis of head and neck cancer were offered enrolment. Twenty-four enrolled and 14 attended the smoking cessation classes. Only two successfully quit smoking at six months. Both these patients were in the financially incentivised group and received $150 at each test visit. CONCLUSION: Providing a financial incentive for smoking cessation to a population already carrying a diagnosis of head and neck cancer in order to promote a positive behaviour change was unsuccessful.
Entities:
Keywords:
Head And Neck Cancer; Incentive Reimbursement; Quality Of Life; Smoking Cessation
Authors: Caitlin Notley; Sarah Gentry; Jonathan Livingstone-Banks; Linda Bauld; Rafael Perera; Jamie Hartmann-Boyce Journal: Cochrane Database Syst Rev Date: 2019-07-17
Authors: Alana M Rojewski; Lisa M Fucito; Nathaniel L Baker; Suchitra Krishnan-Sarin; Matthew J Carpenter; Steven L Bernstein; Benjamin A Toll Journal: Nicotine Tob Res Date: 2021-05-24 Impact factor: 4.244
Authors: Ellie Shingler; Luke A Robles; Rachel Perry; Chris Penfold; Andy R Ness; Steve Thomas; J Athene Lane; Richard M Martin Journal: Head Neck Date: 2018-03-30 Impact factor: 3.147
Authors: Jonathan B Bricker; Noreen L Watson; Jaimee L Heffner; Brianna Sullivan; Kristin Mull; Diana Kwon; Johann Lee Westmaas; Jamie Ostroff Journal: JMIR Form Res Date: 2020-01-17